A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Age range
18 Years – 75 Years
Last updated November 2025